Skip to main content

Table 4 Total hemoglobin concentration of US-DOT according to pathologic biomarkers

From: US-localized diffuse optical tomography in breast cancer: comparison with pharmacokinetic parameters of DCE-MRI and with pathologic biomarkers

 

Total hemoglobin concentration (μmol/L)

  

Mean

p

Tumor size

<2 cm (n = 20)

172.15

0.440

≥2 cm (n = 17)

192.06

 

HG

Low (n = 16)

147.98

0.019

High (n = 21)

206.68

 

ER

Neg (n = 15)

212.27

0.041

Pos (n = 22)

160.02

 

PR

Neg (n = 13)

211.86

0.075

Pos (n = 24)

164.73

 

HER-2

Neg (n = 31)

179.63

0.769

Pos (n = 6)

189.91

 

TNBC

Neg (n = 27)

173.12

0.294

Pos (n = 10)

203.38

 

Ki-67

Low (n = 18)

153.52

0.030

High (n = 19)

207.61

 

LVI

Neg (n = 23)

175.45

0.581

Pos (n = 3)

146.14

 

LN mets

Neg (n = 24)

179.84

0.879

Pos (n = 13)

183.97

 

mets

Neg (n = 36)

180.36

0.663

Pos (n = 1)

214.97

Â